ID: ALA475309

Max Phase: Preclinical

Molecular Formula: C20H23FO

Molecular Weight: 298.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1=C(/C=C/C(=O)/C=C/c2ccc(F)cc2)C(C)(C)CCC1

Standard InChI:  InChI=1S/C20H23FO/c1-15-5-4-14-20(2,3)19(15)13-12-18(22)11-8-16-6-9-17(21)10-7-16/h6-13H,4-5,14H2,1-3H3/b11-8+,13-12+

Standard InChI Key:  CWXSUUAEFSOEDF-OWKCIBLPSA-N

Associated Targets(Human)

LNCaP 8286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

IMR-32 1082 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Aspergillus niger 16508 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Saccharomyces cerevisiae 19171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Candida albicans 78123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nannizzia gypsea 2039 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.40Molecular Weight (Monoisotopic): 298.1733AlogP: 5.49#Rotatable Bonds: 4
Polar Surface Area: 17.07Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.78CX LogD: 5.78
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.67Np Likeness Score: 0.84

References

1. Zhou J, Geng G, Batist G, Wu JH..  (2009)  Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.,  19  (4): [PMID:19138519] [10.1016/j.bmcl.2008.12.089]
2. Sharma V, Singh G, Kaur H, Saxena AK, Ishar MP..  (2012)  Synthesis of β-ionone derived chalcones as potent antimicrobial agents.,  22  (20): [PMID:22999415] [10.1016/j.bmcl.2012.08.084]
3. Sharma V, Chaudhary A, Arora S, Saxena AK, Ishar MP..  (2013)  β-Ionone derived chalcones as potent antiproliferative agents.,  69  [PMID:24056146] [10.1016/j.ejmech.2013.08.017]

Source